Literature DB >> 28489695

CLASSIFICATION OF HALLER VESSEL ARRANGEMENTS IN ACUTE AND CHRONIC CENTRAL SEROUS CHORIORETINOPATHY IMAGED WITH EN FACE OPTICAL COHERENCE TOMOGRAPHY.

Maria C Savastano1, Kunal K Dansingani2,3, Marco Rispoli1,4, Gianni Virgili5, Alfonso Savastano5, K Bailey Freund6,7,8, Bruno Lumbroso1.   

Abstract

PURPOSE: To compare the prevailing patterns of Haller vessel arrangements at the posterior pole between healthy eyes and those with central serous chorioretinopathy (CSC) using en face optical coherence tomography.
METHODS: Eyes of normal subjects and patients with acute or chronic CSC underwent optical coherence tomography imaging (RTVue 100; Optovue Inc, Fremont, CA). En face sections at the level of the Haller layer were classified by two masked graders into five mutually exclusive morphologic categories (temporal herringbone, branched from below, laterally diagonal, double arcuate, and reticular). The relative prevalence of each Haller vessel arrangement pattern was determined for each phenotype.
RESULTS: Numbers of eyes examined were as follows: 154 eyes of 77 normal subjects; 41 eyes of 31 patients with acute CSC; and 39 eyes of 33 patients with chronic CSC. The mean age of participants was 44.4 ± 14.6 years for healthy subjects (M:F = 37:40), 48.5 ± 8.2 years (M:F = 24:7) for acute CSC, and 65.3 ± 13.1 years (M:F = 28:5) for chronic CSC. The relative prevalence of each Haller vessel arrangement pattern differed by phenotype. The temporal herringbone pattern was most prevalent in healthy eyes (49.2%), whereas a reticular pattern was most prevalent in eyes with acute and/or chronic CSC (combined, 48.8%).
CONCLUSION: A significant difference was observed in the prevalence of respective Haller vessel arrangement patterns between eyes of normal subjects and those of patients with either acute or chronic CSC. Although further study is needed to determine the mechanistic factors underlying these differences, and the hemodynamic implications, our data suggest that en face optical coherence tomography may find a formal role in choroidal disease classification.

Entities:  

Mesh:

Year:  2018        PMID: 28489695     DOI: 10.1097/IAE.0000000000001678

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Automated segmentation of en face choroidal images obtained by optical coherent tomography by machine learning.

Authors:  Hideki Shiihara; Shozo Sonoda; Hiroto Terasaki; Naoko Kakiuchi; Yuki Shinohara; Masatoshi Tomita; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2018-10-06       Impact factor: 2.447

2.  Predicting persistent central serous chorioretinopathy using multiple optical coherence tomographic images by deep learning.

Authors:  Donghyun Jee; Ji Hyun Yoon; Ho Ra; Jin-Woo Kwon; Jiwon Baek
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

3.  Variation of vortex veins at the horizontal watershed in normal eyes.

Authors:  Junki Hoshino; Hidetaka Matsumoto; Ryo Mukai; Kosuke Nakamura; Yosuke Arai; Yuka Kikuchi; Shoji Kishi; Hideo Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-24       Impact factor: 3.117

4.  Automated quantification of Haller's layer in choroid using swept-source optical coherence tomography.

Authors:  Sushmitha Rao Uppugunduri; Mohammed Abdul Rasheed; Ashutosh Richhariya; Soumya Jana; Jay Chhablani; Kiran Kumar Vupparaboina
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

5.  Choriocapillaris Flow Impairments in Association with Pachyvessel in Early Stages of Pachychoroid.

Authors:  Jiwon Baek; Lee Kook; Won Ki Lee
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

6.  THE INCIDENCE OF NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  M Cristina Savastano; Marco Rispoli; Bruno Lumbroso
Journal:  Retina       Date:  2021-02-01       Impact factor: 3.975

Review 7.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.